Satellos Bioscience (TSX:MSCL) Total Stockholders Equity : C$34.50 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience Total Stockholders Equity?

Satellos Bioscience's Total Stockholders Equity for the quarter that ended in Mar. 2024 was C$34.50 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Satellos Bioscience's Book Value per Share for the quarter that ended in Mar. 2024 was C$0.31. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Satellos Bioscience's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

Satellos Bioscience Total Stockholders Equity Historical Data

The historical data trend for Satellos Bioscience's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience Total Stockholders Equity Chart

Satellos Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

-0.18

10.48

3.37

40.67

Satellos Bioscience Quarterly Data
	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial										2.13	49.19	46.36	40.67	34.50

Satellos Bioscience (TSX:MSCL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Satellos Bioscience's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(34.501	-	0)	/	112.792
	=	0.31

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Satellos Bioscience's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	34.501
	=	0.00

Satellos Bioscience Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Satellos Bioscience's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Satellos Bioscience (TSX:MSCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (TSX:MSCL) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

MSCLF:USA 0IT:Germany

Address

65 Front Street East, Suite 201, Toronto, ON, CAN, M5E 1B5

Website

https://www.satellos.com

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Satellos Bioscience (TSX:MSCL) Headlines

No Headlines